2021 annual financial data
TScan Therapeutics 2021 Financial results
Direct answer
Revenue was 10.14M USD.
Operating income was -48.64M USD and net income was -48.63M USD.
Operating cash flow was -48.68M USD.
Get free TScan Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 10.14M USD
- Operating income
- -48.64M USD
- Net income
- -48.63M USD
- Operating cash flow
- -48.68M USD
Explore related company data
View all 2021 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Net marginView Operating cash flow marginView all TScan Therapeutics financial years